{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:58:29Z","timestamp":1740146309695,"version":"3.37.3"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gilead Sciences (Greece)"},{"name":"Gilead Sciences (Greece)"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194262","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T17:31:42Z","timestamp":1520962302000},"page":"e0194262","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and correlates of persistent intracellular HIV transcription in individuals on efavirenz versus atazanavir-based regimens: A prospective cohort study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-8027","authenticated-orcid":true,"given":"Dimitrios","family":"Pilalas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lemonia","family":"Skoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolia","family":"Margariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fani","family":"Chatzopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Chatzidimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Tsachouridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis","family":"Zebekakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeon","family":"Metallidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population","volume":"11","author":"G Wandeler","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm.2111","article-title":"HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects","volume":"16","author":"MJ Buz\u00f3n","year":"2010","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit453","article-title":"Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV Infection: A randomized, placebo-controlled trial","volume":"208","author":"H Hatano","year":"2013","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"R Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"C V Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-4690-10-41","article-title":"Cell-associated HIV RNA: a dynamic biomarker of viral persistence","volume":"10","author":"AO Pasternak","year":"2013","journal-title":"Retrovirology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","article-title":"Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs","volume":"14","author":"L Shen","year":"2008","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters","volume":"31","author":"O Kis","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00002030-200109070-00005","article-title":"Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART","volume":"15","author":"BK Patterson","year":"2001","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-60761-789-1_26","article-title":"Simultaneous ultrasensitive subpopulation staining\/hybridization in situ (SUSHI) in HIV-1 disease monitoring","volume":"659","author":"BK Patterson","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/JCM.02539-14","article-title":"Identification and characterization of HIV-1 Latent viral reservoirs in peripheral blood","volume":"53","author":"A Chargin","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1097-0320(19980401)31:4<265::AID-CYTO6>3.0.CO;2-I","article-title":"Detection of HIV-RNA-positive monocytes in peripheral blood of HIV- positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype","volume":"31","author":"BK Patterson","year":"1998","journal-title":"Cytometry"},{"year":"2016","key":"ref14","article-title":"R: A language and environment for statistical computing"},{"key":"ref15","unstructured":"Sundar Dorai-Raj (2014). binom: Binomial Confidence Intervals For Several Parameterizations. R package version 1.1\u20131.<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/CRAN.R-project.org\/package=binom\" xlink:type=\"simple\">https:\/\/CRAN.R-project.org\/package=binom<\/ext-link>"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11904-017-0355-y","article-title":"The Alphabet Soup of HIV Reservoir Markers","volume":"14","author":"RR Sharaf","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref17","first-page":"1641","article-title":"Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia","volume":"24","author":"AO Pasternak","year":"2010","journal-title":"Wolters Kluwer Heal AIDS"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008490","article-title":"Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome","volume":"4","author":"AO Pasternak","year":"2009","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/infdis\/jis630","article-title":"Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells","volume":"208","author":"H Hatano","year":"2013","journal-title":"J Infect Dis"},{"key":"ref20","first-page":"1","article-title":"The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption","volume":"30","author":"JZ Li","year":"2015","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JVI.02139-15","article-title":"Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy","volume":"90","author":"MF Kearney","year":"2016","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"201609057","DOI":"10.1073\/pnas.1609057113","article-title":"Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy","volume":"113","author":"H Imamichi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003871","article-title":"Quantifying the Turnover of Transcriptional Subclasses of HIV-1-Infected Cells","volume":"10","author":"CL Althaus","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","article-title":"If nothing goes wrong, is everything all right? Interpreting zero numerators","volume":"249","author":"JA Hanley","year":"1983","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/infdis\/jis502","article-title":"Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma","volume":"206","author":"AO Pasternak","year":"2012","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/QAI.0b013e3181fe4c89","article-title":"Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapy","volume":"56","author":"F Falasca","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2016.05.001","article-title":"Role and modulation of drug transporters in HIV-1 therapy","volume":"103","author":"C Alam","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2055-6640(20)30490-8","article-title":"HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?","volume":"1","author":"DA Kulpa","year":"2015","journal-title":"J Virus Erad"},{"key":"ref29","first-page":"1","article-title":"Regulatory T cell memory","volume":"16","author":"MD Rosenblum","year":"2015","journal-title":"Nat Rev Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T07:11:06Z","timestamp":1603955466000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194262"}},"subtitle":[],"editor":[{"given":"Graciela","family":"Andrei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194262","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,3,13]]}}}